Collegium Pharmaceutical CEO Joseph Ciaffoni's 2019 pay rises 15% to $4M
Collegium Pharmaceutical reports 2019 executive compensation
By ExecPay News
Published: April 9, 2020
Collegium Pharmaceutical reported fiscal year 2019 executive compensation information on April 9, 2020.
In 2019, five executives at Collegium Pharmaceutical received on average a compensation package of $2.1M, a 19% decrease compared to previous year.
Average pay of disclosed executives at Collegium Pharmaceutical
Joseph J. Ciaffoni, Chief Executive Officer, received $4M in total, which increased by 15% compared to 2018. 53% of Ciaffoni's compensation, or $2.1M, was in stock awards. Ciaffoni also received $391K in non-equity incentive plan, $860K in option awards, $618K in salary, as well as $17K in other compensation.
Richard Malamut, Chief Medical Officer, received a compensation package of $1.9M. 40% of the compensation package, or $765K, was in option awards.
Paul Brannelly, Chief Financial Officer, earned $1.7M in 2019, a 13% decrease compared to previous year.
Shirley Kuhlmann, General Counsel, received $1.4M in 2019, which decreases by 10% compared to 2018.
Alison Fleming, Chief Technology Officer, earned $1.4M in 2019, a 27% decrease compared to previous year.
Related executives
Joseph Ciaffoni
Collegium Pharmaceutical
Chief Executive Officer
Paul Brannelly
Collegium Pharmaceutical
Chief Financial Officer
Alison Fleming
Collegium Pharmaceutical
Chief Technology Officer
Shirley Kuhlmann
Collegium Pharmaceutical
General Counsel
Richard Malamut
Collegium Pharmaceutical
Chief Medical Officer
You may also like
Source: SEC filing on April 9, 2020.